VPRIV

Google image searchProduct monograph

Active ingredient

velaglucerase alfa, 400 UNIT/VIAL

DIN: 02357119

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE USE VIAL

Schedule: Prescription / Schedule D

Company: TAKEDA CANADA INC

Date: 15-OCT-2021

ATC:

• A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
• A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
• A16AB — Enzymes (ATC, ATC/DDD)
• A16AB10 — VELAGLUCERASE ALFA (ATC/DDD)

Reference brand drug: Vpriv

External Links for Vpriv

Search on Google

• Vpriv side effects
• Vpriv dosage
• velaglucerase alfa side effects
• velaglucerase alfa dosage

Takeda Canada Inc

Go to Takeda website to see drug product details. Sometimes you can find vpriv photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.